Upcoming Stock Splits This Week (October 7 to October 11) – Stay Invested [Yahoo! Finance]
OnKure Therapeutics, Inc. - Class A (OKUR)
Company Research
Source: Yahoo! Finance
In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). In this case, too, the market cap is maintained as the share price increases following the reverse stock split. Companies often undertake stock splits to improve the liquidity of the common shares and make them more affordable for retail investors. Let's look quickly at the upcoming stock splits for the week. ams OSRAM AG (AMSSY) – Austria-based ams OSRAM AG is a semiconductor company that manufactures advanced light and sensor technologies. The company's unsponsored ADRs (American Depositary Receipts) are set to undergo a one-for-ten reverse stock split. The ADRs are expected to start trading on a split-adjusted basis on October 7. Reneo Pharmaceuticals (RPHM) – Reneo Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. On
Show less
Read more
Impact Snapshot
Event Time:
OKUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OKUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OKUR alerts
High impacting OnKure Therapeutics, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
OKUR
News
- OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.MarketBeat
- OnKure to Present at the Stifel 2024 Healthcare ConferenceGlobeNewswire
- OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]Yahoo! Finance
- OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer SymposiumGlobeNewswire
- OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond [Seeking Alpha]Seeking Alpha
OKUR
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/7/24 - Form 424B3
- OKUR's page on the SEC website